Tailoring of Immunosuppression With Belatacept in De Novo and Conversion Settings and Risk Mitigation Strategies. Formica RN, Larsen CP, Rostaing L. Transplantation 2026;110:e302-e323.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Formica RN, Larsen CP, Rostaing L. Tailoring of Immunosuppression With Belatacept in De Novo and Conversion Settings and Risk Mitigation Strategies. Transplantation 2026;110:e302-e323.
PMID: 40898400